Rituximab, Ifosfamide, Carboplatin, and Etoposide (RICE) Followed by Gallium Nitrate, Rituximab and Dexamethasone (GARD) for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
PHASE2
The purpose of this study is to find out what effects, good and/or bad; rit...
Status
Withdrawn
Location
Loyola Univeristy Medical Center, Cardinal Bernardin Cancer Center
Study of Rituximab-HCVAD Alternating With Rituximab-Methotrexate-Cytarabine Versus Standard Rituximab-CHOP Every 21 Days for Patients With Newly Diagnosed High Risk Aggressive B-Cell Non-Hodgkin's Lymphomas in Patients 60 Years Old or Younger
PHASE2
The overall goal of this clinical research study was to find out which of t...